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TABLE 1 Associations Between BAC (Presence vs. Absence and
Severe vs. Absent) and Incident Cardiovascular Disease and Diabetes
BAC Presence
BAC Severity
Severe
HR (95% CI) p Value HR (95% CI) p Value
Composite CVD endpoint
Model 1 1.16 (0.92-1.48) 0.215 2.25 (1.29-3.94) 0.005
Model 2 1.44 (1.04-1.99) 0.030 3.54 (1.89-6.64) <0.001
Model 3 1.39 (1.00-1.93) 0.048 3.37 (1.80-6.31) <0.001
Coronary heart disease
Model 1 1.22 (0.94-1.58) 0.130 2.40 (1.34-4.29) 0.003
Model 2 1.46 (1.04-2.05) 0.028 3.50 (1.82-6.72) <0.001
Model 3 1.44 (1.02-2.01) 0.036 3.40 (1.76-6.57) <0.001
Stroke
Model 1 1.19 (0.83-1.72) 0.338 2.29 (1.13-4.63) 0.022
Model 2 1.47 (0.98-2.19) 0.059 3.21 (1.51-6.83) 0.003
Model 3 1.39 (0.92-2.08) 0.116 2.85 (1.32-6.15) 0.008
Peripheral artery disease
Model 1 0.97 (0.61-1.55) 0.912 1.59 (0.62-4.07) 0.335
Model 2 1.43 (0.80-2.58) 0.231 3.24 (1.16-9.00) 0.025
Model 3 1.37 (0.74-2.52) 0.313 2.93 (1.05-8.16) 0.040
Incident diabetes
Model 1 0.75 (0.51-1.08) 0.125 1.27 (0.58-2.78) 0.555
Model 2* 0.88 (0.58-1.33) 0.542 1.24 (0.48-3.17) 0.658
BAC ¼ breast arterial calciﬁcation; CI ¼ conﬁdence interval; CVD ¼ cardiovascular disease; HR ¼
hazard ratio; Model 1 ¼ age-adjusted; Model 2 ¼ multivariable adjusted for age, smoking, high-
density lipoprotein (HDL)/total cholesterol ratio, hypertension, physical activity, body mass index,
alcohol intake, type 2 diabetes, cardiovascular disease history, parity number, menopausal status;
Model 2* ¼ multivariable adjusted for age, body mass index, physical activity, HDL/total
cholesterol ratio and smoking; Model 3 ¼ model 2 plus pulse pressure.
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860develop medial calciﬁcation in other vascular beds,
this needs further investigation. One study in renal
patients showed that BAC was associated with
medial calciﬁcation in other arterial beds (4). It is
hypothesized that medial calciﬁcation leads to CVD
through increased arterial stiffness (5). This is sup-
ported by our data, because we found that adding
pulse pressure attenuated the associations. A limited
number of studies conducted in speciﬁc patient
groups reported increased cardiovascular risks asso-
ciated with medial calciﬁcation in other vascular
beds, comparable to those we found for severe
BAC (5).
The presence of BAC is modestly associated with
CVD, with an approximately 3-fold increased risk for
severe BAC, independent of traditional risk factors.
This indicates a possible contribution of a medial,
nonatherosclerotic pathway to CVD.*Eva J.E. Hendriks, MD
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Aortic and Aortic Valve
Disease and the Risk
for Sudden Death in
Competitive AthletesSudden deaths (SDs) in young athletes are unex-
pected, tragic, and highly visible events. Consider-
able attention has been focused on pre-participation
screening to prevent these events (1). Aortic stenosis
(AS) is known as an important cause of SD in the
young, whereas aortic dissection/rupture is a cata-
strophic condition not usually associated with demise
early in life (2,3). The role of these diseases in athletic
ﬁeld deaths and their identiﬁcation by standard
routine pre-participation screening (e.g., history and
physical examination in the United States) is incom-
pletely understood.
The U.S. National Registry of Sudden Death in
Athletes, a forensic and clinical database that collects
SDs of competitive athletes under 40 years of age (4),
FIGURE 1 Results of Pre-Participation Screening in 34 Competitive Athletes
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*Includes 4 athletes with 12-lead electrocardiograms. †Includes 3 athletes in whom some
modiﬁed restrictions to competitive sports participation were recommended. AD ¼ aortic
disease; AS ¼ aortic stenosis; CV ¼ cardiovascular disease.
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861was accessed for deaths due to aortic disease (AD)
and AS. Data collection techniques and sources have
been outlined previously (4), largely on the basis of
public domain information, including the LexisNexis
database. Data on pre-participation screening and
cause of death were obtained through autopsy re-
ports, media accounts, and correspondence with
decedents’ families and high schools/colleges. Data
are presented as mean  SD.
Of the 2,588 deaths in the registry, 44 (1.7%) were
due to AS (n ¼ 19) or AD (n ¼ 25). AD (suspected
Marfan syndrome in 12 athletes, including 2 with a
ﬁbrillin mutation) was due to rupture in 23 (15 with
identiﬁed dissection) and aortic coarctation in 2 ath-
letes. Surgical repair was attempted in 1 athlete. Of
those with AS, 12 had bicuspid valves, including
4 with dilated ascending aorta. Athletes were 17.6 
5.1 years of age (age range: 11 to 36 years); 40 were
male and 4 female. With regard to race, 29 (65%)
athletes were white, 10 (23%) were black, and 5 (11%)
were Hispanic.
The most frequent sports were football and
basketball (n ¼ 13 each) and baseball/softball (n ¼ 7).
Two athletes with aortic dissections were lifting
weights at the time of collapse. AS deaths occurred
during or just after exercise in 18 of 19 athletes; AD
deaths occurred during exercise (n ¼ 16), while
sedentary (n ¼ 6), or during sleep (n ¼ 2). Therefore,
34 of 44 athlete deaths were associated with exertion
during practice or competition.
Pre-participation history and physical examination
screening data were available in 34 athletes (Figure 1).
A total of 19 athletes (56%; 5 AS, 14 AD) were cleared
for competition without suspicion of cardiovascular
disease. In the other 15 athletes (44%; 10 AS, 5 AD),
cardiovascular disease was identiﬁed or suspected
with specialized cardiac testing, but each of these
athletes returned to competition. Notably, 8 athletes
(AS 2, AD 6) were evaluated for chest/back/abdominal
pain shortly before collapse, and 3 were discharged
from the emergency room <24 h before death.
These data in athletes who died suddenly under-
score the importance of AS and AD as potentially
identiﬁable causes of death. These data are particu-
larly pertinent to the ongoing discussion in cardi-
ology regarding pre-participation screening and
criteria for disqualiﬁcation versus eligibility (1). Of
note, in these athletes, pre-participation screening
frequently failed to detect AS or AD. However, it is
possible that the American Heart Association 14-item
history and physical examination recommendations
would have raised suspicion of heart disease by virtue
of a systolic murmur (for AS) or body habitus (for AD)
in many (1). We cannot predict what the effect of12-lead electrocardiographic screening would have
been on the detection of AS and AD (1). Because there
is no mandatory reporting of sudden athlete deaths, it
is possible our registry under-reported some of these
events.
Despite raising the suspicion or recognition of
cardiovascular disease through screening, 15 other
athletes were not disqualiﬁed from sports and con-
tinued to compete, including 11 who eventually died
during physical exertion while training or in compe-
tition. These recommendations for continued eligi-
bility in competitive sports were largely inconsistent
with Bethesda Conference 36 guidelines (2,5).
Although potentially identiﬁable by history/phys-
ical examination, which is the standard screening
model in the United States, there was no suspicion
of AD or AS during screening in the majority of ath-
letes. Of the remaining athletes who were identiﬁed
as having cardiovascular disease, standard consensus
criteria were not employed to reduce risk or prevent
SD by disqualiﬁcation from sports.
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Detected on Coronary
CT Angiography Predicts
Acute Coronary SyndromeThe study by Puchner et al. (1) revealed that the
presence of high-risk plaque features on coronary
computed tomography angiography (CTA) in patients
presenting to the emergency department with acute
chest pain, but negative initial electrocardiogram and
troponin, increases the likelihood of acute coronary
syndrome (ACS). This is independent of the presence
of signiﬁcant coronary artery disease and clinical risk
assessment (age, sex, number of cardiovascular risk
factors).
First, patients in this study were recruited between
April 2010 and January 2012, and hence, at least 2-
year medium-term clinical follow-up would be
available, but the primary endpoint of this study was
ACS during index hospitalization. ACS was deﬁned as
acute myocardial infarction (MI) or unstable anginapectoris that was pre-deﬁned and adjudicated by an
independent clinical events committee. This study
included 472 patients, and only 37 patients had ACS.
It is not clearly stated in the body of the paper how
many patients had acute MI, or how many went on to
have invasive coronary angiography and revascular-
ization. It would have been clearer if the authors
elaborated on this in the body of the paper. It is of
further interest for the authors to report whether
high-risk features on CTA predict these harder clin-
ical endpoints. A recent study by Nasis et al. (2)
reported the long-term outcome (median follow-up
of 47.4 months) of 585 consecutive patients who
underwent CTA assessment in the emergency
department, and the event rate for coronary revas-
cularization was 6.2% (n ¼ 34). It is therefore of in-
terest that Puchner and colleagues report whether
high-risk or “vulnerable plaque” features in this
study predicted longer-term ACS, coronary revascu-
larization, and mortality as well.
Second, the assessment of plaque burden, which
has been the strongest independent predictor of long-
term ACS (3), was not reported in this study. It would
have been of signiﬁcant interest to compare high-risk
plaque features with plaque burden for prediction of
short-term and long-term ACS in this study.
Third, the authors deﬁned low attenuation plaque
as <30 HU on the basis of previously published
criteria described by Motoyama et al. (4), who used a
tube voltage of 135 kV. The scanner parameters were
not described by Puchner et al. (1). Could Puchner and
colleagues (1) speculate about the applicability of the
low attenuation plaque deﬁnition used in their study
if the tube voltage differed from that in the study by
Motoyama et al. (4)?*Dennis T.L. Wong, MBBS (Hons), PhD
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